US Patent Issued to Medicenna Therapeutics, The United States of America, as represented by the Secretary, Department of Health and Human Services on Dec. 23 for "Interleukin-4 receptor-binding fusion proteins and uses thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,496, issued on Dec. 23, was assigned to Medicenna Therapeutics Inc. (Toronto) and The United States of America, as represented by the Secretary, Department of Health and Human Services (Silver Spring, Md.).

"Interleukin-4 receptor-binding fusion proteins and uses thereof" was invented by Fahar Merchant (Vancouver, Canada), Raj K. Puri (Potomac, Md.) and Bharatkumar H. Joshi (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to interleukin-4 receptor-binding fusion proteins. More specifically, the invention provides, in part, fusion proteins that include an interleukin-4 or interleukin-13 protein moiety joine...